Add Yahoo as a preferred source to see more of our stories on Google. Although there are more than 100 conditions that fall under the umbrella term "arthritis," an autoimmune disease called rheumatoid ...

Biologics for rheumatoid arthritis (RA) are generally quick-acting and effective, but their effectiveness and the time it takes to see results can vary. Many are FDA approved, including adalimumab, ...

Crescendo Bioscience, creators of the Vectra DA blood test to predict the progression of rheumatoid arthritis (RA), is gaining market share in the United States, with its new parent company, Myriad ...

Please provide your email address to receive an email when new articles are posted on . Exagen Diagnostics has announced the launch of the first validated blood test to detect anticarbamylated protein ...

Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list ...

A rheumatoid factor test checks for an antibody that can be a marker for rheumatoid arthritis. It is one part of diagnosis. Not everyone with a positive rheumatoid factor blood test has rheumatoid ...

Precision medicine company Aqtual has secured $31m in a Series B financing round to progress its active chromatin cell-free DNA (cfDNA) platform and launch a rheumatoid arthritis (RA) therapy response ...

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

Oct. 28, 2003 (Orlando) -- The presence of antibodies to cyclic citrullinated peptides (CCP) may accurately predict the likelihood of developing rheumatoid arthritis (RA) in patients with recent-onset ...

Patients with rheumatoid arthritis (RA) are likely to benefit from regular high-sensitivity cardiac troponin T (hs-cTnT) testing, researchers said. In a group of RA patients followed for a mean of 5 ...